Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

As Shutdown Continues, Hospital Attys Face Tired Clients No Photo Available

Yeji Jesse Lee

As the government shutdown passes the one-week mark, hospital administrators facing potential financial hits and other heartache from ... (more story)

DOJ Deal In Medicare Fraud Case A 'Slap On The Wrist' No Photo Available

Hannah Albarazi

Healthcare startup Troy Medicare had big ambitions to revolutionize senior care in the Medicare Advantage market before justice offici... (more story)

Arizona Ruling Delivers Trans Victory Amid Federal Scrutiny No Photo Available

Dan McKay

A recent court order that bars Arizona from requiring proof of surgery before transgender people can change a birth certificate contin... (more story)